Tanvex BioPharma, Inc. (TPE:6541)
Taiwan · Delayed Price · Currency is TWD 60.10
-1.20 (-1.96%)
Dec 23, 2025, 1:35 PM CST
Tanvex BioPharma Market Cap
Tanvex BioPharma has a market cap or net worth of 15.92 billion as of December 23, 2025. Its market cap has increased by 46.75% in one year.
Market Cap
15.92B
Enterprise Value
16.07B
Revenue
224.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
60.10
Market Cap Chart
Since August 13, 2015, Tanvex BioPharma's market cap has decreased from 16.77B to 15.92B, a decrease of -5.10%. That is a compound annual growth rate of -0.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 15.92B | 48.78% |
| Dec 31, 2024 | 10.70B | 22.75% |
| Dec 29, 2023 | 8.71B | -29.59% |
| Dec 30, 2022 | 12.38B | -39.56% |
| Dec 30, 2021 | 20.48B | 106.96% |
| Dec 31, 2020 | 9.89B | -9.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 252.02B |
| PharmaEssentia | 183.81B |
| Heron Neutron Medical | 82.63B |
| Lotus Pharmaceutical | 75.08B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 32.01B |
| Oneness Biotech | 28.18B |